Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

24/10/2022 09:00

Oct 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              821.45              677.49                     
                   (+21.2 pct)         (+17.5 pct)                  
  Operating          383.84              282.84                     
                   (+35.7 pct)         (+24.4 pct)                  
  Pretax
  Net                271.95              204.15                     
                   (+33.2 pct)         (+25.7 pct)                  
  EPS Basic        165.35 yen          124.17 yen                   
  EPS Diluted      165.29 yen          124.09 yen                   
  Ann Div                               76.00 yen        76.00 yen  
  -Q2 Div           38.00 yen           30.00 yen                   
  -Q4 Div                               46.00 yen        38.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T